Connecting Pharma SRL
Connecting Pharma reported total assets of 312,342 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of Connecting Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -49 % Total assets -27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Connecting Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 44,241 € | ||||
| Equity | 137,271 € | ||||
| Cash | 231,970 € | ||||
| EBITDA | 66,954 € | ||||
| Total assets | 312,342 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 May 2022filed on 29 Nov 2022
- Year ended 31 May 2021filed on 17 Dec 2021
Connecting Pharma's financial analysis
- Solvency43.9%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Connecting Pharma
Connecting Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.826.628
- VAT number
- BE0846826628
- Peppol
- Registered · 0208:0846826628 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jun 2012
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Connecting Pharma (SRL) has been based in Ghent since 2012, active in: business and other management consultancy activities. For 2025, it reports a net profit of 44,241 € and equity of 137,271 €; its revenue is not published. Its solvency stands at 43.9%, below the median of its sector (58.4%).
Companies similar to Connecting Pharma
Companies in the same business, of comparable size and area, outside its group.
- HiPhaQS Business and other management consultancy activities Neupré · balance sheet 197,185 €
- Elgan Consultancy Business and other management consultancy activities Menen · balance sheet 261,683 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- C-That Manufacture of basic pharmaceutical products Hasselt · balance sheet 379,706 €
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- Vaxconsult Business and other management consultancy activities Uccle · balance sheet 358,716 €
- T & Tech Network Associates Business and other management consultancy activities Uccle · balance sheet 330,130 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
Frequently asked questions about Connecting Pharma
What is the revenue of Connecting Pharma?
Connecting Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Connecting Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0846826628 for Connecting Pharma, if the company is VAT-registered. Its company number (CBE) is 0846.826.628.
Where is the registered office of Connecting Pharma?
According to the CBE register, the registered office of Connecting Pharma is in 9000 Ghent.
What is the equity of Connecting Pharma?
At the close of the 2025 financial year, the equity of Connecting Pharma amounts to 137,271 €, a solvency of 43.9% of total assets.
Who manages Connecting Pharma?
The register lists 1 active mandates at Connecting Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Connecting Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →